Series B Investors & VC Firms in United States
1637 firms in this list, with a median first check of $540K. 475 of them lead rounds. Generated from verified public data and updated continuously.
Evening
Mountain ViewSeed–Series B$50K – $100K
8 people
Richmond Global Ventures
New YorkPre-Seed–Series B$200K – $2M
3 people
Marlinspike Partners
ArlingtonSeed–Late Stage
14 people
sequel
San FranciscoPre-Seed–Series C$100K – $3M
8 people
Daft Capital
Palo AltoPre-Seed–Series B$500K – $2M
1 person
Access Biotechnology
New YorkSeed–Late Stage
4 people
Advection Growth Capital
New York CitySeed–Series B
4 people
CRE Venture Capital
MahwahPre-Seed–Growth$50K – $1M
4 people
SnowPoint Ventures
West Palm BeachSeries A–Late Stage
11 people
Maximus Ventures
Seed–Series C
15 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
The Colorado Impact Fund
DenverSeed–Growth$500K – $2M
6 people
Black Diamond Ventures
GlendalePre-Seed–Growth$2M – $10M
8 people
Conexo Ventures
BostonSeed–Growth
5 people
Figure 8 Investments
AshevilleSeed–Series B$50K – $500K
3 people
Global Health Investment Corporation
New YorkSeed–Series B
5 people
IPD Capital
AventuraSeed–Series B
8 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
West Capital
AlpineSeries A–Growth
9 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Blossom Street Ventures
DallasSeries A–Growth$1M – $4M
1 person
Healthier Capital
Menlo ParkSeed–Series B
9 people
OCV Partners
Los AngelesSeed–Series B
6 people
Oval Park Capital
RaleighSeed–Series B$500K – $1.5M
3 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Seed Investors & VC Firms (12239)Series A Investors & VC Firms (7512)Seed Investors & VC Firms in North America (6489)Investors & VC Firms in Europe (6083)Pre-Seed Investors & VC Firms (5991)Seed Investors & VC Firms in United States (5809)Investors & VC Firms in Global (5318)Growth Investors & VC Firms (4560)
Data sourced from public filings and firms' own websites — see our methodology.




















































































